Moneycontrol
HomeNewsWorldApple supplier Foxconn pushed China to ease COVID curbs
Trending Topics

Apple supplier Foxconn pushed China to ease COVID curbs

The appeal, sent by Gou in a letter more than a month ago, played a major role in convincing China's leadership to quickly reopen the economy and move away from its zero-tolerance COVID-19 policies, the report said on Thursday, citing people familiar with the matter.

December 09, 2022 / 07:16 IST
Story continues below Advertisement

Foxconn

Apple supplier Foxconn's founder-director Terry Gou had warned China that the government's zero-COVID stance would threaten the position of the world's second-largest economy in the global supply chain, the Wall Street Journal reported.

The appeal, sent by Gou in a letter more than a month ago, played a major role in convincing China's leadership to quickly reopen the economy and move away from its zero-tolerance COVID-19 policies, the report said on Thursday, citing people familiar with the matter.

Story continues below Advertisement

Foxconn, which is the biggest assembler of iPhones, declined to comment, while Gou's office did not immediately respond. China's State Council Information Office could not be immediately reached for comment.

The Taiwan-based company's Zhengzhou plant, which saw a month-long unrest in November, has lifted its "closed-loop" management curbs on Thursday.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show